Novo Nordisk A/S Cash Conversion Cycle 2011-2026 | NVO

Annual Cash Conversion Cycle Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	286	279	256	250	233	207	218	247

All numbers in DKK currency

Maximum	Minimum	Average
286	207	247

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	173	$ 3.54	-0.7 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Aptorum Group Limited APM	-400	$ 0.8	1.81 %	$ 4.36 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	21.2	$ 6.62	-0.15 %	$ 181 M	Israel
BioCardia BCDA	101	$ 1.35	6.29 %	$ 28.6 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Catalyst Biosciences CBIO	71.5	$ 11.29	-2.51 %	$ 1.01 B	USA
Anika Therapeutics ANIK	270	$ 14.58	1.53 %	$ 214 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
AVEO Pharmaceuticals AVEO	-123	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.69	1.7 %	$ 16.9 M	USA
Curis CRIS	103	$ 0.89	3.74 %	$ 5.61 M	USA